Price TJ et al. |
A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons. |
2005 |
Neuropharmacology |
pmid:15992578
|
Bouaboula M et al. |
Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. |
2005 |
Eur. J. Pharmacol. |
pmid:15987634
|
Glaser ST et al. |
Anandamide transport: a critical review. |
2005 |
Life Sci. |
pmid:15979096
|
Hohmann AG et al. |
An endocannabinoid mechanism for stress-induced analgesia. |
2005 |
Nature |
pmid:15973410
|
Tian X et al. |
The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer. |
2005 |
J. Biol. Chem. |
pmid:15964843
|
Ambrosi S et al. |
On the importance of anandamide structural features for its interactions with DPPC bilayers: effects on PLA2 activity. |
2005 |
J. Lipid Res. |
pmid:15961786
|
Karava V et al. |
Anandamide metabolism by Tetrahymena pyriformis in vitro. Characterization and identification of a 66 kDa fatty acid amidohydrolase. |
2005 |
Biochimie |
pmid:15951097
|
Gamber KM et al. |
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. |
2005 |
Neuropharmacology |
pmid:15949823
|
Ueda N et al. |
N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines. |
2005 |
Life Sci. |
pmid:15949819
|
Justinova Z et al. |
The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. |
2005 |
J. Neurosci. |
pmid:15944392
|
Balas L et al. |
Synthesis of a photoactivatable probe of the anandamide re-uptake. |
2005 |
Nat. Prod. Res. |
pmid:15938150
|
Abalo R et al. |
Evaluation of the effect of age on cannabinoid receptor functionality and expression in guinea-pig ileum longitudinal muscle-myenteric plexus preparations. |
2005 Jul 22-29 |
Neurosci. Lett. |
pmid:15936532
|
De Petrocellis L and Di Marzo V |
Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels. |
2005 |
Life Sci. |
pmid:15936040
|
Fowler CJ et al. |
The endocannabinoid signaling system: pharmacological and therapeutic aspects. |
2005 |
Pharmacol. Biochem. Behav. |
pmid:15935456
|
Bojesen IN and Hansen HS |
Membrane transport of anandamide through resealed human red blood cell membranes. |
2005 |
J. Lipid Res. |
pmid:15930521
|
Kwolek G et al. |
[Influence of anandamide, the endogenous agonist of cannabinoid receptors on the circulatory system]. |
2005 |
Postepy Hig Med Dosw (Online) |
pmid:15928605
|
Myrdal SE and Steyger PS |
TRPV1 regulators mediate gentamicin penetration of cultured kidney cells. |
2005 |
Hear. Res. |
pmid:15925202
|
Bari M et al. |
Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. |
2005 |
J. Neurosci. Res. |
pmid:15920744
|
Ortega-Gutiérrez S et al. |
Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. |
2005 |
Glia |
pmid:15920730
|
Ahern GP et al. |
Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling. |
2005 |
J. Neurosci. |
pmid:15917451
|
Jia Y et al. |
TRPV1 receptor: a target for the treatment of pain, cough, airway disease and urinary incontinence. |
2005 |
Drug News Perspect. |
pmid:15915217
|
Hillard CJ and Jarrahian A |
Accumulation of anandamide: evidence for cellular diversity. |
2005 |
Neuropharmacology |
pmid:15910883
|
Venderova K et al. |
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. |
2005 |
Exp. Neurol. |
pmid:15899265
|
Vandevoorde S and Fowler CJ |
Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. |
2005 |
Br. J. Pharmacol. |
pmid:15895107
|
van der Stelt M et al. |
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. |
2005 |
FASEB J. |
pmid:15894565
|
Kaplan BL et al. |
Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide. |
2005 |
Toxicol. Appl. Pharmacol. |
pmid:15893538
|
Guo Y et al. |
N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. |
2005 |
J. Biol. Chem. |
pmid:15890658
|
Ashton CH et al. |
Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. |
2005 |
J. Psychopharmacol. (Oxford) |
pmid:15888515
|
Osei-Hyiaman D et al. |
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. |
2005 |
J. Clin. Invest. |
pmid:15864349
|
Glass M et al. |
Misidentification of prostamides as prostaglandins. |
2005 |
J. Lipid Res. |
pmid:15863842
|
Pisani A et al. |
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. |
2005 |
Ann. Neurol. |
pmid:15852389
|
Mishima K et al. |
Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. |
2005 |
Stroke |
pmid:15845890
|
Siegmund SV et al. |
Anandamide induces necrosis in primary hepatic stellate cells. |
2005 |
Hepatology |
pmid:15841466
|
Monteleone P et al. |
Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. |
2005 |
Neuropsychopharmacology |
pmid:15841111
|
Kwolek G et al. |
Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. |
2005 |
Br. J. Pharmacol. |
pmid:15834445
|
Randall MD |
The cardiovascular actions of anandamide: more targets? |
2005 |
Br. J. Pharmacol. |
pmid:15834438
|
Chen JZ et al. |
Preferred conformations of endogenous cannabinoid ligand anandamide. |
2005 |
Life Sci. |
pmid:15826873
|
Chen J et al. |
Finding of endocannabinoids in human eye tissues: implications for glaucoma. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15823551
|
O'Sullivan SE et al. |
The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide. |
2005 |
Br. J. Pharmacol. |
pmid:15821751
|
Pacher P et al. |
Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15821037
|
Tóth A et al. |
Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1. |
2005 |
Life Sci. |
pmid:15820503
|
Kvasnicka T |
[Endocannabinoids--the new option in the treatment of metabolic syndrome and in smoking cessation]. |
2005 |
Cas. Lek. Cesk. |
pmid:15807291
|
Kurabayashi M et al. |
2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. |
2005 Jan-Feb |
J Invest Surg |
pmid:15804949
|
Chen P et al. |
Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. |
2005 |
Microvasc. Res. |
pmid:15797258
|
Fowler CJ and Tiger G |
Cyclooxygenation of the arachidonoyl side chain of 1-arachidonoylglycerol and related compounds block their ability to prevent anandamide and 2-oleoylglycerol metabolism by rat brain in vitro. |
2005 |
Biochem. Pharmacol. |
pmid:15794945
|
De Bank PA et al. |
A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening. |
2005 |
Biochem. Pharmacol. |
pmid:15794939
|
Sandberg A and Fowler CJ |
Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin. |
2005 |
Chem. Phys. Lipids |
pmid:15784231
|
Minowa S et al. |
Capsaicin- and anandamide-induced gastric acid secretion via vanilloid receptor type 1 (TRPV1) in rat brain. |
2005 |
Brain Res. |
pmid:15781048
|
Fezza F et al. |
Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity. |
2005 |
Anal. Biochem. |
pmid:15766717
|
Zhang N et al. |
A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15764707
|
Domenicali M et al. |
Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. |
2005 |
Gut |
pmid:15753538
|
Mestre L et al. |
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. |
2005 |
J. Neurochem. |
pmid:15748152
|
Wiley JL et al. |
Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. |
2005 |
Eur. J. Pharmacol. |
pmid:15740725
|
Oddi S et al. |
Confocal microscopy and biochemical analysis reveal spatial and functional separation between anandamide uptake and hydrolysis in human keratinocytes. |
2005 |
Cell. Mol. Life Sci. |
pmid:15723173
|
Lam PM et al. |
Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids. |
2005 |
Br J Anaesth |
pmid:15722382
|
Oz M et al. |
Additive effects of endogenous cannabinoid anandamide and ethanol on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15687372
|
Rodella LF et al. |
AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation. |
2005 |
Eur. J. Pharmacol. |
pmid:15680264
|
Kohro S et al. |
Reductions in levels of bacterial superantigens/cannabinoids by plasma exchange in a patient with severe toxic shock syndrome. |
2004 |
Anaesth Intensive Care |
pmid:15675223
|
Mbvundula EC et al. |
Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage. |
2005 |
Biochem. Pharmacol. |
pmid:15670582
|
Kim SR et al. |
Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. |
2005 |
J. Neurosci. |
pmid:15659603
|
O'Sullivan SE et al. |
Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. |
2005 |
Eur. J. Pharmacol. |
pmid:15659311
|
Bari M et al. |
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. |
2005 |
J. Biol. Chem. |
pmid:15657045
|
Oz M et al. |
Effects of saturated long-chain N-acylethanolamines on voltage-dependent Ca2+ fluxes in rabbit T-tubule membranes. |
2005 |
Arch. Biochem. Biophys. |
pmid:15639235
|
Gavva NR et al. |
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15615864
|
Dinis P et al. |
Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. |
2004 |
J. Neurosci. |
pmid:15601931
|
Braun M and Kietzmann M |
Ischaemia-reperfusion injury in the isolated haemoperfused bovine uterus: an in vitro model of acute inflammation. |
2004 |
Altern Lab Anim |
pmid:15601235
|
Fegley D et al. |
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15579492
|
Patel S et al. |
The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. |
2005 |
J. Lipid Res. |
pmid:15576840
|
Maccarrone M et al. |
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. |
2005 |
Mol. Hum. Reprod. |
pmid:15563449
|
Rossato M et al. |
Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. |
2005 |
J. Clin. Endocrinol. Metab. |
pmid:15562018
|
López-Miranda V et al. |
Anandamide vehicles: a comparative study. |
2004 |
Eur. J. Pharmacol. |
pmid:15556148
|
Mukherjee S et al. |
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15556131
|
RodrÃguez de Fonseca F et al. |
The endocannabinoid system: physiology and pharmacology. |
2005 Jan-Feb |
Alcohol Alcohol. |
pmid:15550444
|
Basavarajappa BS and Hungund BL |
Role of the endocannabinoid system in the development of tolerance to alcohol. |
2005 Jan-Feb |
Alcohol Alcohol. |
pmid:15550443
|
Golech SA et al. |
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. |
2004 |
Brain Res. Mol. Brain Res. |
pmid:15548432
|
Muthian S et al. |
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. |
2004 |
Neuroscience |
pmid:15541895
|
Habayeb OM et al. |
Plasma levels of the endocannabinoid anandamide in women--a potential role in pregnancy maintenance and labor? |
2004 |
J. Clin. Endocrinol. Metab. |
pmid:15531501
|
Holt S et al. |
Lipopolysaccharide-induced pulmonary inflammation is not accompanied by a release of anandamide into the lavage fluid or a down-regulation of the activity of fatty acid amide hydrolase. |
2004 |
Life Sci. |
pmid:15530507
|
Triggle CR et al. |
The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes. |
2004 |
Mol. Cell. Biochem. |
pmid:15524164
|
McFarland MJ and Barker EL |
Anandamide transport. |
2004 |
Pharmacol. Ther. |
pmid:15518883
|
Lanzafame AA et al. |
Effects of anandamide on the binding and signaling properties of M1 muscarinic acetylcholine receptors. |
2004 |
Biochem. Pharmacol. |
pmid:15498511
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Fernández-Rodriguez CM et al. |
Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. |
2004 |
Liver Int. |
pmid:15482346
|
Piomelli D |
The endogenous cannabinoid system and the treatment of marijuana dependence. |
2004 |
Neuropharmacology |
pmid:15464150
|
Huitron-Resendiz S et al. |
Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase. |
2004 |
Sleep |
pmid:15453543
|
Contassot E et al. |
Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. |
2004 |
J. Neuropathol. Exp. Neurol. |
pmid:15453094
|
Bátkai S et al. |
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. |
2004 |
Circulation |
pmid:15451779
|
RodrÃguez de Fonseca F |
[The endocannabinoid system and food intake control]. |
2004 Apr-Jun |
Rev Med Univ Navarra |
pmid:15382609
|
Movsesyan VA et al. |
Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways. |
2004 |
Cell Death Differ. |
pmid:15375383
|
Appendino G et al. |
Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15356216
|
Giuffrida A et al. |
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. |
2004 |
Neuropsychopharmacology |
pmid:15354183
|
Di Marzo V et al. |
The anandamide membrane transporter. Structure-activity relationships of anandamide and oleoylethanolamine analogs with phenyl rings in the polar head group region. |
2004 |
Bioorg. Med. Chem. |
pmid:15351399
|
McAllister SD et al. |
Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation. |
2004 |
J. Biol. Chem. |
pmid:15326174
|
Oka S et al. |
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. |
2004 |
J. Leukoc. Biol. |
pmid:15316028
|
Blázquez C et al. |
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. |
2004 |
Cancer Res. |
pmid:15313899
|
Wiley JL et al. |
A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. |
2004 |
Exp Clin Psychopharmacol |
pmid:15301634
|
Do Y et al. |
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. |
2004 |
J. Immunol. |
pmid:15294950
|
Lazzarin N et al. |
Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. |
2004 |
Gynecol. Endocrinol. |
pmid:15293893
|
McFarland MJ et al. |
A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. |
2004 |
J. Biol. Chem. |
pmid:15292270
|
De Petrocellis L et al. |
Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. |
2004 |
Br. J. Pharmacol. |
pmid:15289293
|